Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Shulkin

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Obstetrics and Gynecology|March 1, 1984
Amenorrhea-galactorrhea, hyperprolactinemia, and suprasellar pituitary enlargement as presenting features of primary hypothyroidismT R Groff, B L Shulkin, R D Utiger, et al.
Journal of Neurochemistry|March 1, 1995
Inhibition of neutral amino acid transport across the human blood-brain barrier by phenylalanineB L Shulkin, A L Betz, R A Koeppe, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumorsB Shapiro, J C Sisson, B L Shulkin, et al.
Clinical Nuclear Medicine|June 1, 1988
Scintigraphic portrayal of the syndrome of multiple endocrine neoplasia type-2BJ J Yobbagy, R Levatter, J C Sisson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imagingV Rufini, G A Fisher, B L Shulkin, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumorsB Shapiro, J C Sisson, B L Shulkin, et al.
American Journal of Clinical Oncology|April 1, 1996
Survival of patients with neuroblastoma treated with 125-I MIBGJ C Sisson, B Shapiro, R J Hutchinson, et al.
Journal of Pediatric Hematology/Oncology|July 1, 1997
PET FDG studies of Wilms tumorsB L Shulkin, E Chang, P J Strouse, et al.
Endocrinology|September 1, 1983
Preincubation of thyroxine with sulfhydryl-reducing agents does not stimulate thyroxine inner or outer ring deiodinationB L Shulkin, R D Utiger, C H Emerson, et al.
Radiology|July 16, 1999
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PETB L Shulkin, N W Thompson, B Shapiro, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Obstetrics and Gynecology|March 1, 1984
Amenorrhea-galactorrhea, hyperprolactinemia, and suprasellar pituitary enlargement as presenting features of primary hypothyroidismT R Groff, B L Shulkin, R D Utiger, et al.
Journal of Neurochemistry|March 1, 1995
Inhibition of neutral amino acid transport across the human blood-brain barrier by phenylalanineB L Shulkin, A L Betz, R A Koeppe, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumorsB Shapiro, J C Sisson, B L Shulkin, et al.
Clinical Nuclear Medicine|June 1, 1988
Scintigraphic portrayal of the syndrome of multiple endocrine neoplasia type-2BJ J Yobbagy, R Levatter, J C Sisson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imagingV Rufini, G A Fisher, B L Shulkin, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumorsB Shapiro, J C Sisson, B L Shulkin, et al.
American Journal of Clinical Oncology|April 1, 1996
Survival of patients with neuroblastoma treated with 125-I MIBGJ C Sisson, B Shapiro, R J Hutchinson, et al.
Journal of Pediatric Hematology/Oncology|July 1, 1997
PET FDG studies of Wilms tumorsB L Shulkin, E Chang, P J Strouse, et al.
Endocrinology|September 1, 1983
Preincubation of thyroxine with sulfhydryl-reducing agents does not stimulate thyroxine inner or outer ring deiodinationB L Shulkin, R D Utiger, C H Emerson, et al.
Radiology|July 16, 1999
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PETB L Shulkin, N W Thompson, B Shapiro, et al.
Pageof 7